3Jiang W. Proceeding of the American Association for Cancer Research,the effects of CyclinEh on grow thcontrol, cell cycle rogression and gene expression[J]. Cancer Res,1994,54(1) :27
4Hunter T,Pines J. Cyclins and cancer Ⅱ：cyclin D and CDK inhibitors come of age[J]. Cell, 1994,79(6) ：573
5Lawrence Z. The molecular basis of dysplasia[J]. Seminars in Diagn Pathol,2002,19(1) :48 - 53
2Wang H, Song K, Chen ZG, et al. Poor metabolizers at the cytochrome P450 2C19 loci is at increased risk of developing cancer in Asian popu- lations[J]. PLoS One,2013,8(8) :117-121.
3Bo Z, Song ZS, Qian MP, et al. Functional polymorphisms in the CYP2C19 gene contribute to digestive system cancer risk :evidence from 11,042 subjects [ J 1. Digestive System Cancer Genetics, 2013,8 ( 7 ) : 147-150.
4Liang S,Hu JS,Cao WJ,et al. Meta-Analysis of cytochrome P-450 2C9 polymorphism and colorectal cancer risk [ J ]. PLoS 0ne,2012,7 (11 ) : 1212-1216.
5lsomura Y, Yamaji Y, Ohta M, eta|. A genetic polymorphism of CYP2C19 is associated with susceptibility to biliary tract cancer[J]. J Gastroentero1,2010,45 (10) : 1045-1052.
6Yao L, Wang HC, Liu JZ, et al. Quantitative assessment of the influence of cytochrome 17450 2C19 gene polymorphisms and digestive tract cancer risk[J]. Tumor Biology,2013,34(5 ) :3083-3091.
7Wang F,Zou YF,Sun GP,et al. Association of CYP1B1 gene polymor- phisms with susceptibility to endometrial cancer: a meta-analysis [ J ]Eur J Cancer Prevent,2011,20 (2) : 112-120.
8Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer[ J]. N EngI J Med,2011,345 (6) :784-789.
9Sugimoto M, Furuta T, Shirai N, et al. Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection [ J ]. Aliment Pharmacol Ther, 2011,22(2) :1033-1040.
